Sheel Biotech Limited (NSE:SHEEL)

Sheel Biotech Statistics

Total Valuation

Sheel Biotech has a market cap or net worth of INR 1.32 billion. The enterprise value is 1.59 billion.

Market Cap	1.32B
Enterprise Value	1.59B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Sheel Biotech has 20.35 million shares outstanding. The number of shares has increased by 0.56% in one year.

Current Share Class	20.35M
Shares Outstanding	20.35M
Shares Change (YoY)	+0.56%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	63.65%
Owned by Institutions (%)	n/a
Float	5.68M

Valuation Ratios

The trailing PE ratio is 6.54.

PE Ratio	6.54
Forward PE	n/a
PS Ratio	1.18
PB Ratio	1.57
P/TBV Ratio	1.57
P/FCF Ratio	75.96
P/OCF Ratio	47.79
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.25, with an EV/FCF ratio of 91.37.

EV / Earnings	10.89
EV / Sales	1.42
EV / EBITDA	8.25
EV / EBIT	8.69
EV / FCF	91.37

Financial Position

The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.32.

Current Ratio	3.54
Quick Ratio	1.65
Debt / Equity	0.32
Debt / EBITDA	1.40
Debt / FCF	15.54
Interest Coverage	10.19

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	14.41%
Return on Capital Employed (ROCE)	19.78%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Sheel Biotech has paid 21.26 million in taxes.

Income Tax	21.26M
Effective Tax Rate	12.70%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	73.33
200-Day Moving Average	n/a
Relative Strength Index (RSI)	38.25
Average Volume (20 Days)	19,800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sheel Biotech had revenue of INR 1.12 billion and earned 146.09 million in profits. Earnings per share was 9.94.

Revenue	1.12B
Gross Profit	406.31M
Operating Income	183.13M
Pretax Income	167.35M
Net Income	146.09M
EBITDA	192.91M
EBIT	183.13M
Earnings Per Share (EPS)	9.94

Balance Sheet

The company has 2.05 million in cash and 270.59 million in debt, with a net cash position of -268.55 million or -13.19 per share.

Cash & Cash Equivalents	2.05M
Total Debt	270.59M
Net Cash	-268.55M
Net Cash Per Share	-13.19
Equity (Book Value)	840.61M
Book Value Per Share	57.97
Working Capital	795.29M

Cash Flow

In the last 12 months, operating cash flow was 27.68 million and capital expenditures -10.27 million, giving a free cash flow of 17.42 million.

Operating Cash Flow	27.68M
Capital Expenditures	-10.27M
Free Cash Flow	17.42M
FCF Per Share	0.86

Margins

Gross margin is 36.17%, with operating and profit margins of 16.30% and 13.01%.

Gross Margin	36.17%
Operating Margin	16.30%
Pretax Margin	14.90%
Profit Margin	13.01%
EBITDA Margin	17.17%
EBIT Margin	16.30%
FCF Margin	1.55%

Dividends & Yields

Sheel Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.56%
Shareholder Yield	-0.56%
Earnings Yield	11.04%
FCF Yield	1.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2